Inhibition effects of 5-S-glutathionyl-N-β-alanyl-L-dopa analogues against Src protein tyrosine kinase

Chemical and Pharmaceutical Bulletin

Volumn 47, Issue 6, 1999, Pages 777-782

  Zheng, Zhe Bin ^a   Nagai, Sachie ^a   Iwanami, Naoko ^a   Kobayashi, Ayako ^b   Natori, Shunji ^b   Sankawa, Ushio ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

C Src; EGFR; Protein tyrosine kinase; Raytide; V Src

Indexed keywords

5 S GLUTATHIONYL N BETA ALANYL LEVODOPA; ANTIBIOTIC AGENT; GLUTATHIONYL N BETA ALANYL LEVODOPA DERIVATIVE; HERBIMYCIN A; MONOPHENOL MONOOXYGENASE; NATURAL PRODUCT; PEPTIDE; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ARTICLE; AUTOPHOSPHORYLATION; DRUG ISOLATION; DRUG MECHANISM; DRUG SYNTHESIS; FLY; NONHUMAN; ONCOGENE SRC;

EID: 0032975329     PISSN: 00092363     EISSN: None     Source Type: Journal    
DOI: 10.1248/cpb.47.777     Document Type: Article

References (23)

1. Leem J. Y., Nishimura C., Kurata S., Shimada I., Kobayashi A., Natori S., J. Biol. Chem., 271, 13573-13577 (1996).
2. Natori S., UCLA Symp. Mol. Cell. Biol. New Ser., 49, 369-378 (1987).
3. Boman H. G., Cell, 65, 205-207 (1991).
4. Kanai A., Natori S., FEBS Lett., 258, 199-202 (1989).
5. Ito S., Prota G., Experientia, 33, 1118-1119 (1977).
6. Prota G., Thomson R. H., Endeavour, 35, 32-38 (1976).
7. Agrup G., Agrup P., Anderson T., Falck B., Hanson J. A., Jacobsson S., Rorsman H., Rosengren A. M., Rosengren E., Acta Dermatovener (Stockholm), 55, 337-341 (1975).
8. Fujita K., Ito S., Inoue S., Yamamoto Y., Takeuchi J., Shamoto M., Nagatsu T., Cancer Res., 40, 2543-2546 (1980).
9. Ito S., Inoue S., Yamamoto Y., Fujita K., J. Med. Chem., 24, 673-677 (1981).
10. Ito S., Inoue S., Fujita K., Biochemical Pharmacology, 32, 2079-2081 (1983).
11. Hijikata M., Kobayashi A., Leem J. Y., Fukasawa H., Uehara Y., Natori S., Biochem. Biophys. Res. Commun., 237, 423-426 (1997).
12. Zheng Z. B., Nagai S., Iwanami N., Kobayashi A., Hijikata M., Natori S., Sankawa U., Chem. Pharm. Bull., 46, 1950-1951 (1998).
13. Fukazawa H., Li P. M., Mizuno S., Uehara Y., Anal. Biochem., 212, 106-110 (1993).
14. CALBIOCHEM, Oncogene Research Products Manual, Assay Method with c-Src and Substrate Raytide.
15. Bertics P. J., Gill G. N., J. Biol. Chem., 260, 14642-14647 (1985).
16. Uehara Y., Fukazawa H., Murakami Y., Mizuno S., Biochem. Biophys. Res. Commun., 163, 803-809 (1989).
17. Zheng Z.B., Nagai S., Iwanami N., Kobayashi A., Hijikata M., Natori S., Sankawa U., Chem. Pharm. Bull., 47, 136-137 (1999).
18. Chang C. J., Geahlen R. L., J. Nat. Prod., 55, 1529-1560 (1992).
19. Kakeya H., Imoto M., Tababa Y., Iwami J., Matsumoto H., Nakamura K., Koyano T., Tadano K., Umezawa K., FEBS Lett., 320, 169-172 (1993).
20. Hanke J. H., Gardner J. P., Dow R. L., Changelian P. S., Brissette W. H., Weringer E. J., Pollok B. A., Connelly P. A., J. Biol. Chem., 271, 695-701 (1996).
21. Levitzki A., Anti-Cancer Drug Design, 11, 175-182 (1996).
22. Coy D. H., Coy E. J., Lee K. Y., Chey W. Y., Peptides, 3, 137-141 (1982).
23. Fournier A., Saunders J. K., Pierre S., Peptides, 5, 169-177 (1984).